Repare Therapeutics Inc.

NASDAQ: RPTX · Real-Time Price · USD
1.58
0.02 (1.28%)
At close: Aug 15, 2025, 3:59 PM
1.57
-0.63%
After-hours: Aug 15, 2025, 04:04 PM EDT

Repare Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-84.69M -93.8M -29.05M -106.91M
Depreciation & Amortization
1.92M 1.95M 1.98M 1.47M
Stock-Based Compensation
23.17M 25.06M 19.69M 12.83M
Other Working Capital
-18M -57.12M 10.9M 4.64M
Other Non-Cash Items
-2.79M -5.19M -3.94M 1.87M
Deferred Income Tax
n/a n/a 3.62M 149K
Change in Working Capital
-14.06M -55.18M 8.03M 4.79M
Operating Cash Flow
-76.44M -127.16M 322K -85.8M
Capital Expenditures
n/a -1.94M -602K -1.69M
Cash Acquisitions
n/a n/a 175.18M 40K
Purchase of Investments
-133.35M -179.02M -256.58M -7.48M
Sales Maturities Of Investments
182.82M 259M 81.4M 7.45M
Other Investing Acitivies
n/a n/a -175.18M n/a
Investing Cash Flow
49.47M 78.04M -175.78M -1.68M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a n/a 1.27M
Financial Cash Flow
542K 842K 880K 95.56M
Net Cash Flow
-26.55M -48.25M -174.91M 8.03M
Free Cash Flow
-76.44M -129.1M -280K -87.49M